The 16th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.

TARGET AUDIENCE

Hepatologists, Radiologists, Surgeons, Nurses, Allied Healthcare Professionals, Fellows, and Residents.

LEARNING OBJECTIVES

At the conclusion of this program, participants will be able to:

• Diagnose and develop a treatment strategy for acute kidney injury in patients with cirrhosis.
• Identify indications and evaluation for liver transplantation, as well as the role of MELD in organ allocation.
• Review the pros and cons of Transjugular Intrahepatic Portosystemic Shunts (TIPS) in patients with cirrhosis and portal hypertension, including expanding indications.
• Implement new and novel strategies for the treatment of hepatocellular carcinoma (HCC).
• Discuss specific liver disorders and injuries in women, as well as pregnancy hepatic complications.
• Treat non-alcoholic fatty liver disease and be able to employ noninvasive tests for diagnosis and risk stratification.
• Review the treatment of alcohol hepatitis, including long-term follow up, and understand controversies associated with early liver transplantation.
• Discuss updates in the management of patients with viral hepatitis B, including those immunotolerant, and considerations for stopping antiviral therapy.
• Diagnose acute liver failure, and risk stratify patients according to available laboratory results and clinical parameters.